The Cannabis Trades Association (CTA) is calling out the Food Standards Agency’s (FSA) failure to support the Cannabidiol (CBD) and hemp industry in meeting the Novel Foods application deadline during the coronavirus crisis.
Mile High Labs has submitted a European novel foods dossier for its CBD isolate. According to Christian Hendriksen, vice president of international expansion, compliance with novel food regulations will help move CBD into the FMCG mainstream.
The Association for the Cannabinoid Industry (ACI) reveals details of a three-tiered certification scheme that looks to provide safety and quality assurances for cannabidiol (CBD)-based products.
Despite the cancellation of Natural Products Expo West, many brands are pushing ahead and insisting the show must go on. From supplements for first responders to multivitamins for babies, the latest products to launch offer something for everyone.
The increasing popularity of cannabidiol (CBD) only underscores the need for accurate and informative labeling of hemp and hemp-derived CBD products, according to researchers.
The UK’s advertising watchdog has dismissed claims made by a retailer stating its cannabidiol (CBD) pain relief patch could reduce chronic pain, anxiety and diabetes, pointing out the claims were medicinal.
One of the pioneers of the space topped $53 million in annual revenue, but also recorded a loss as the founders cashed out. The firm also said regulatory uncertainty has increased competition as numerous small brands crowd into the field.
The side effects of cannabidiol (CBD) products are ‘most probably’ due to native THC contamination rather than by direct action of CBD or its chemical transformation, according to a German-led study.
The German Food and Agriculture Ministry (BMEL) has refuted an EU hemp group missive that the Ministry had changed its position regarding the novel food requirement for some cannabidiol (CBD) extracts in the EU.
British, European and international cannabidiol (CBD) players are throwing millions of euros at EU novel food dossiers to meet the UK’s recently issued 2021 sector ultimatum to clean up its act or clear off the market.
By Hank Schultz, Elaine Watson and Elizabeth Crawford
A report on CBD delivered by FDA Commissioner Dr Stephen Hahn, MD, was seen by food and dietary supplement industry stakeholders as offering little hope of a timely regulatory solution for the ingredient.
With just over a week to go before the CBD Global Summit kicks off in London, time is running out to register for this must-attend event spotlighting opportunities in an exciting and provocative category.
A GP and an entrepreneur frustrated by a lack of legitimate, high quality CBD products have launched their own supplements brand built on trust and transparency which they hope will thrive in an increasingly well-regulated space.
A compound made by cannabis plants has been found to wipe out one of the most common drug-resistant bacteria in a study on mice, raising hopes of a new weapon in the fight against superbugs.
FDA Commissioner Dr Stephen Hahn, MD, in a speech on Wednesday, said that despite its continued concern about insufficient safety data, the FDA has no plans to try to shut down the CBD markets. Hahn said that would amount to a “fool’s game.”
The Food Safety Authority of Ireland (FSAI) has updated its recall of CBD-related foods and food supplements that have flagged up safety concerns due to the presence of delta‐9‐tetrahydrocannabinol or THC.
Retailers in the CBD space have expressed frustration at a recent survey, which finds products analysed breach food law with some posing as potential safety risks for consumers.
After an explosive start in late 2019 (it sold 200,000 cans in 36 hours on Black Friday via its website) LIFEAID has secured listings in 350 Vitamin Shoppe stores (in CBD-friendly states), Lucky’s Market in Colorado, and New Seasons for its new CBD-infused...
Cannabidiol (CBD) industry groups have welcomed new regulatory and precautionary advice by UK authorities highlighting its “clear trajectory towards developing a safe and legally compliant CBD industry.”
A higher court in Germany rules that cannabidiol (CBD) is a novel food confirming the decision made by one of the country’s administrative courts back in November last year.
The authors of a new study have suggested the CBD sector is mired by inconsistent quality, concentrations, pricing and labelling. “What we encountered was a wild, wild west scenario in terms of manufacturing and marketing,” Noa Gans, head of product at...
An analysis of recent warning letters underscores the notion that FDA is focused its enforcement efforts on CBD, and is not targeting hemp extracts per se.
Despite all the buzz around CBD and the near steady stream of product launches across food and beverage categories featuring the ingredient, the majority of Americans have not heard of the ingredient, never used it or have no interest in it, according...
From the complexities of regulation and cutting-edge science to the brands behind the boom, the CBD Global Summit will bridge the business and science underpinning this fast-moving category.
Nutraceutical and cannabinoid product manufacturer Medlab are teaming up with UK-based distributors Cultech to expand its probiotic and cannabidiol (CBD) products’ reach into Europe.
A synthetic form of vitamin E may be behind the spate of vaping-associated lung injuries caused as a result of smoking cannabis oil (tetrahydrocannabinol/THC) using an e-cigarette cartridge.
By Stefan Gafner and Mark Blumenthal, American Botanical Council
The news about CBD and hemp extracts dominated 2019, says the American Botanical Council. But issues surrounding the ongoing climate crisis, questions of sustainability, and the ongoing questions of adulteration were important topics as well.
By Steve Mister, President & CEO, Council for Responsible Nutrition
The question of CBDs, and of a mandatory product listing, have dominated a year that for the dietary supplement industry has not been as tumultuous as some.
CBDepot has applied for Novel Food (NF) application for a synthetic form of cannabidiol (CBD) for food supplement use in a move the firm says has a better chance of regulatory approval.
By Daniel Fabricant, PhD, CEO and President of the Natural Products Association (NPA)
2019 will be remembered as the year Cannabidiol (CBD) hit the American mainstream. From Ben and Jerry’s Ice Cream to pet food and hand lotions to vape pens, CBD is everywhere we look. Which is why it is easy to understand why the majority of Americans...
The US Food and Drug Administration has stated that it cannot conclude that CBD (cannabidiol) is generally recognized as safe (GRAS) for its use in human food, based on a “lack of scientific information supporting the safety of CBD in food”.
Defendants in a recent spate of lawsuits alleging discrepancies between the amount of CBD advertised on pack and the amount contained in the products, have hit back in motions to dismiss, with one arguing that such cases should be stayed until the FDA...
CBD has caught the public's imagination as an ingredient offering a host of potential health benefits. But for all the hype, CBD also courts controversy. To move from a trending ingredient to an ingredient trend, the sector will need to address some...
The Journal of Dietary Supplements is planning a special issue devoted to the toxicology, pharmacology, and potential regulatory pathways for CBD and other cannabinoids, and is inviting submissions.
Germany’s federal government now confirms that cannabidiol (CBD) is to be classified as novel food citing an absence of evidence of its consumption before 15 May 1997.
Endo Sport launches the UK’s first CBD-infused sports drink that harnesses the active ingredient’s anti-inflammatory properties to help reduce post-exercise muscle soreness and aid recovery.
Athletes using cannabidiol (CBD) products should be prepared for a very real risk they could fail anti-doping tests due to contamination of banned tetrahydrocannabinol (THC), ESSNA has warned.
The United Natural Products Alliance has announced a new policy on hemp extracts while at the same time announcing its first member engaged exclusively in the business.
Cannabis Trades Association (CTA) members will not submit a Novel Foods application for its cannabis containing products as it cites the uncertainty of the regulation’s scope as the main reason.
A cannabidiol (CBD) manufacturer is calling for greater regulatory controls after independent analyses of 31 CBD-based products found varying levels of active ingredients as well as CBD-related labelling issues.
Hemp and CBD continued to reign as one of the top food and beverage trends at Natural Products Expo East in Baltimore last week, just as they did at the event’s counterpart Expo West last March – but also just like at West they were far from the only...
Microbial detection company Hygiena says cannabis is rapidly expanding as an ingredient in foods such as baked goods, oils, drinks and butter, but due to its popularity companies run a higher risk of producing contaminated and unsafe products.
Europe’s cannabidiol food and supplements market was on display at a recent CBD expo in Berlin, with CBD supplement and cosmetic manufacturers reporting impressive margins in a controversial category defined by booming sales and baffling regulations.
The US market for foods and beverages featuring hemp-derived CBD – from relaxation drinks to gummies – could be worth $2.5bn by 2023, or 10.5% of an estimated $23.7bn market for CBD products (spanning everything from pharmaceuticals to petfood), predicts...
Editor's Spotlight: Notes from Nutrition 2019 in Baltimore, June 8-11
Is there a role for cannabis and its derivatives to play in our food system, perhaps as part of a healthy, well-balanced diet? Scientists explored the question at the recent Nutrition 2019 conference in Baltimore.
Bulgaria could be the first country in Europe to permit the sale of hemp-derived cannabidiol (CBD) nutraceutical products on the open market, granting authorisation to US-based firm Kannaway.
When it comes to legally marketing conventional food and dietary supplements with CBD and other cannabis-derived compounds, FDA and industry appear stuck in a catch-22.
